Dendritic cell activation and cytokine response in vaccine breakthrough TBE patients after

Humans Encephalitis, Tick-Borne Cytokines Leukocytes, Mononuclear Viral Vaccines Interleukin-12 Dendritic Cells
cytokines dendritic cells immune response in vitro tick-borne encephalitis vaccine breakthrough

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 21 03 2023
accepted: 03 05 2023
medline: 5 6 2023
pubmed: 1 6 2023
entrez: 1 6 2023
Statut: epublish

Résumé

Tick-borne encephalitis (TBE) is a viral infection of the human central nervous system caused by the TBE virus (TBEV). The most effective protective measure against TBE is vaccination. Despite the highly immunogenic vaccine, cases of vaccine breakthroughs (VBTs) occur. One of the first targets of infection is dendritic cells (DC), which represent a fundamental bridge between innate and adaptive immunity through antigen presentation, costimulation, and cytokine production. Therefore, we investigated the activation and maturation of DCs and cytokine production after

Identifiants

DOI: 10.3389/fimmu.2023.1190803 PMID: 37261350 PMC: PMC10228714
pubmed: 37261350
doi: 10.3389/fimmu.2023.1190803
pmc: PMC10228714
doi:

Substances chimiques

Cytokines 0
Viral Vaccines 0
Interleukin-12 187348-17-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1190803

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

Copyright © 2023 Marušić, Kopitar, Korva, Knap, Bogovič, Strle, Ihan and Avšič-Županc.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Immunol. 2016 Oct 1;197(7):2762-71
pubmed: 27543616
J Immunol. 2014 Mar 15;192(6):2744-55
pubmed: 24532583
Biochem Biophys Res Commun. 2017 Oct 28;492(4):533-540
pubmed: 28167278
J Virol. 2018 Mar 14;92(7):
pubmed: 29321318
Front Cell Infect Microbiol. 2021 Jul 01;11:696337
pubmed: 34277474
J Leukoc Biol. 2008 Oct;84(4):1028-38
pubmed: 18653464
Annu Rev Immunol. 2013;31:163-94
pubmed: 23298212
Nat Immunol. 2011 Jul 10;12(8):786-95
pubmed: 21743478
J Med Virol. 2012 Aug;84(8):1274-8
pubmed: 22711356
Nat Med. 2004 Dec;10(12):1366-73
pubmed: 15558055
Cell Host Microbe. 2011 Sep 15;10(3):185-96
pubmed: 21925107
J Neuroinflammation. 2016 Oct 24;13(1):277
pubmed: 27776548
Virol J. 2011 Jan 26;8:39
pubmed: 21269456
Lancet. 2008 May 31;371(9627):1861-71
pubmed: 18514730
J Virol. 2014 Nov;88(21):12202-12
pubmed: 25122777
Eur J Immunol. 2013 Jul;43(7):1789-98
pubmed: 23568450
Virology. 1996 May 15;219(2):357-66
pubmed: 8638401
Nat Immunol. 2009 Jan;10(1):116-125
pubmed: 19029902
Infect Dis Clin North Am. 2008 Sep;22(3):561-75, x
pubmed: 18755391
Clin Exp Immunol. 2006 Feb;143(2):345-56
pubmed: 16412060
Nat Immunol. 2004 Oct;5(10):987-95
pubmed: 15454922
J Neuroimmunol. 1998 May 1;85(1):1-10
pubmed: 9626992
Eur J Clin Microbiol Infect Dis. 1992 Oct;11(10):894-900
pubmed: 1486884
Vaccine. 2009 Nov 23;27(50):7027-30
pubmed: 19786143
Vaccine. 2009 Nov 23;27(50):7021-6
pubmed: 19789092
Vaccine. 2011 Oct 6;29(43):7307-19
pubmed: 21843576
Hum Vaccin. 2009 Aug;5(8):551-6
pubmed: 19430202
Virology. 2006 Jan 5;344(1):119-30
pubmed: 16364743
Vaccine. 2009 Sep 18;27(41):5543-9
pubmed: 19647065
Sci Transl Med. 2015 Jul 22;7(297):297ra115
pubmed: 26203083
Vaccine. 2005 May 9;23(25):3232-5
pubmed: 15837226
Emerg Infect Dis. 2013 May;19(5):806-8
pubmed: 23697658
Vaccines (Basel). 2021 Jun 17;9(6):
pubmed: 34204532
Clin Exp Immunol. 2003 Jan;131(1):148-54
pubmed: 12519399
J Infect Dis. 2011 May 15;203(10):1415-24
pubmed: 21398396
Immunol Rev. 1996 Oct;153:47-83
pubmed: 9010719
Immunol Cell Biol. 2007 Jan;85(1):33-42
pubmed: 17146465
Vaccine. 2010 Apr 1;28(16):2827-31
pubmed: 20167301
PLoS Negl Trop Dis. 2016 Mar 03;10(3):e0004499
pubmed: 26938618
J Neuroimmunol. 1996 Jan;64(1):37-43
pubmed: 8598388
Immunology. 2018 May;154(1):3-20
pubmed: 29313948
PLoS One. 2011;6(5):e20472
pubmed: 21629771
PLoS One. 2012;7(3):e34145
pubmed: 22461903
PLoS Pathog. 2021 Apr 15;17(4):e1009505
pubmed: 33857267
Vaccine. 2007 Oct 23;25(43):7559-67
pubmed: 17869389
J Intern Med. 2017 Aug;282(2):142-155
pubmed: 28440879
World J Clin Cases. 2015 May 16;3(5):430-41
pubmed: 25984517
Microorganisms. 2021 Jun 30;9(7):
pubmed: 34209373

Auteurs

Miša Marušić (M)

Laboratory for Diagnostics of Zoonoses and World Health Organisation (WHO) Center, Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Andreja Nataša Kopitar (AN)

Laboratory for Cellular Immunology, Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Miša Korva (M)

Laboratory for Diagnostics of Zoonoses and World Health Organisation (WHO) Center, Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Nataša Knap (N)

Laboratory for Diagnostics of Zoonoses and World Health Organisation (WHO) Center, Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Petra Bogovič (P)

Department of Infectious Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia.

Franc Strle (F)

Department of Infectious Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia.

Alojz Ihan (A)

Laboratory for Cellular Immunology, Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Tatjana Avšič-Županc (T)

Laboratory for Diagnostics of Zoonoses and World Health Organisation (WHO) Center, Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Dendritic cell activation and cytokine...
questionsmedicales.fr › Maladies du système nerveux › Encéphalite › Encéphalite infectieuse › Encéphalite virale › Encéphalite à arbovirus › Encéphalites à tiques › Dendritic cell activation and cytokine...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Dendritic cell activation and cytokine...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Dendritic cell activation and cytokine...
questionsmedicales.fr › Mélanges complexes › Produits biologiques › Vaccins › Vaccins antiviraux › Dendritic cell activation and cytokine...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Cytokines › Interleukines › Interleukine-12 › Dendritic cell activation and cytokine...
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Système phagocytaire mononucléé › Cellules dendritiques › Dendritic cell activation and cytokine...